199 related articles for article (PubMed ID: 17541741)
21. Evaluation and Comparison of Citalopram and Venlafaxine for Management of Hot Flashes in Women with Breast Cancer.
Taleghani SY; Etesam F; Esfandbod M
Drug Res (Stuttg); 2023 Oct; 73(8):465-472. PubMed ID: 37647930
[TBL] [Abstract][Full Text] [Related]
22. Randomized trial of black cohosh for the treatment of hot flashes among women with a history of breast cancer.
Jacobson JS; Troxel AB; Evans J; Klaus L; Vahdat L; Kinne D; Lo KM; Moore A; Rosenman PJ; Kaufman EL; Neugut AI; Grann VR
J Clin Oncol; 2001 May; 19(10):2739-45. PubMed ID: 11352967
[TBL] [Abstract][Full Text] [Related]
23. Hot flashes and their management in breast cancer.
Carpenter JS
Semin Oncol Nurs; 2000 Aug; 16(3):214-25. PubMed ID: 10967794
[TBL] [Abstract][Full Text] [Related]
24. Prospective evaluation of vitamin E for hot flashes in breast cancer survivors.
Barton DL; Loprinzi CL; Quella SK; Sloan JA; Veeder MH; Egner JR; Fidler P; Stella PJ; Swan DK; Vaught NL; Novotny P
J Clin Oncol; 1998 Feb; 16(2):495-500. PubMed ID: 9469333
[TBL] [Abstract][Full Text] [Related]
25. The nature of tamoxifen action in the control of female breast cancer.
Kodama M; Kodama T
In Vivo; 2001; 15(4):319-25. PubMed ID: 11695224
[TBL] [Abstract][Full Text] [Related]
26. Acupuncture for the treatment of hot flashes in patients with breast cancer receiving antiestrogen therapy: a pilot study in Korean women.
Jeong YJ; Park YS; Kwon HJ; Shin IH; Bong JG; Park SH
J Altern Complement Med; 2013 Aug; 19(8):690-6. PubMed ID: 23383974
[TBL] [Abstract][Full Text] [Related]
27. Black cohosh (Cimicifuga racemosa) in tamoxifen-treated breast cancer patients with climacteric complaints - a prospective observational study.
Rostock M; Fischer J; Mumm A; Stammwitz U; Saller R; Bartsch HH
Gynecol Endocrinol; 2011 Oct; 27(10):844-8. PubMed ID: 21231853
[TBL] [Abstract][Full Text] [Related]
28. Ask the doctor. I've been taking tamoxifen for several months after completing treatment for breast cancer. My doctor prescribed it primarily to lower my risk of developing cancer in my unaffected breast. As a result of chemotherapy, I underwent menopause abruptly. Tamoxifen has worsened my symptoms, especially hot flashes and vaginal dryness. Other than stopping the tamoxifen, are there ways to deal with the side effects?
Nicholson CR
Harv Womens Health Watch; 1999 May; 6(9):8. PubMed ID: 10198465
[No Abstract] [Full Text] [Related]
29. [The effects of tamoxifen on the female genital tract].
Mourits MJ; van der Zee AG; Willemse PH; Hollema H; de Vries EG
Ned Tijdschr Geneeskd; 2003 Nov; 147(47):2315-20. PubMed ID: 14669536
[TBL] [Abstract][Full Text] [Related]
30. Long-term toxicities of selective estrogen-receptor modulators and antiaromatase agents.
Mortimer JE; Urban JH
Oncology (Williston Park); 2003 May; 17(5):652-9; discussion 659, 662, 666 passim. PubMed ID: 12800793
[TBL] [Abstract][Full Text] [Related]
31. Optimal systemic therapy for premenopausal women with hormone receptor-positive breast cancer.
Jankowitz RC; McGuire KP; Davidson NE
Breast; 2013 Aug; 22 Suppl 2():S165-70. PubMed ID: 24074781
[TBL] [Abstract][Full Text] [Related]
32. Side effects of aromatase inhibitors versus tamoxifen: the patients' perspective.
Garreau JR; Delamelena T; Walts D; Karamlou K; Johnson N
Am J Surg; 2006 Oct; 192(4):496-8. PubMed ID: 16978958
[TBL] [Abstract][Full Text] [Related]
33. Dietary change and reduced breast cancer events among women without hot flashes after treatment of early-stage breast cancer: subgroup analysis of the Women's Healthy Eating and Living Study.
Pierce JP; Natarajan L; Caan BJ; Flatt SW; Kealey S; Gold EB; Hajek RA; Newman VA; Rock CL; Pu M; Saquib N; Stefanick ML; Thomson CA; Parker B
Am J Clin Nutr; 2009 May; 89(5):1565S-1571S. PubMed ID: 19339393
[TBL] [Abstract][Full Text] [Related]
34. Selective estrogen-receptor modulators in 2001.
O'Regan RM; Gradishar WJ
Oncology (Williston Park); 2001 Sep; 15(9):1177-85, 1189-90; discussion 1190-4. PubMed ID: 11589065
[TBL] [Abstract][Full Text] [Related]
35. Effects of tibolone on climacteric symptoms and quality of life in breast cancer patients--data from LIBERATE trial.
Sismondi P; Kimmig R; Kubista E; Biglia N; Egberts J; Mulder R; Planellas J; Moggio G; Mol-Arts M; Kenemans P
Maturitas; 2011 Dec; 70(4):365-72. PubMed ID: 22030384
[TBL] [Abstract][Full Text] [Related]
36. Gene testing to predict tamoxifen-induced hot flashes: new biological insights.
Crandall CJ
J Clin Oncol; 2008 Dec; 26(36):5841-2. PubMed ID: 19018077
[No Abstract] [Full Text] [Related]
37. Transdermal clonidine for ameliorating tamoxifen-induced hot flashes.
Goldberg RM; Loprinzi CL; O'Fallon JR; Veeder MH; Miser AW; Mailliard JA; Michalak JC; Dose AM; Rowland KM; Burnham NL
J Clin Oncol; 1994 Jan; 12(1):155-8. PubMed ID: 8270972
[TBL] [Abstract][Full Text] [Related]
38. The role of selective estrogen receptor modulators on breast cancer: from tamoxifen to raloxifene.
Lee WL; Cheng MH; Chao HT; Wang PH
Taiwan J Obstet Gynecol; 2008 Mar; 47(1):24-31. PubMed ID: 18400579
[TBL] [Abstract][Full Text] [Related]
39. Menopausal symptoms among breast cancer patients: a potential indicator of favorable prognosis.
Chen Y; Dorjgochoo T; Bao PP; Zheng Y; Cai H; Lu W; Shu XO
PLoS One; 2013; 8(9):e75926. PubMed ID: 24098745
[TBL] [Abstract][Full Text] [Related]
40. A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer.
Goss PE; Ingle JN; Martino S; Robert NJ; Muss HB; Piccart MJ; Castiglione M; Tu D; Shepherd LE; Pritchard KI; Livingston RB; Davidson NE; Norton L; Perez EA; Abrams JS; Therasse P; Palmer MJ; Pater JL
N Engl J Med; 2003 Nov; 349(19):1793-802. PubMed ID: 14551341
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
